Wan-Jen Hong

Wan-Jen Hong is a highly experienced medical professional currently serving as the Senior Vice President and Head of Oncology Clinical Development at Dren Bio, Inc. since November 2024. Concurrently, Wan-Jen holds the position of Adjunct Clinical Assistant Professor in the Department of Medicine-Hematology at Stanford University School of Medicine, a role held since September 2014. Prior experience includes Senior Vice President of Clinical Development at Prelude Therapeutics, Chief Medical Officer at Imago BioSciences, and various leadership roles at Genentech. Education includes a Doctor of Medicine (M.D.) from Stanford University School of Medicine and a Bachelor's Degree in Chemical Engineering and Biology from the Massachusetts Institute of Technology.